Catalytic Asymmetric Formal [3+2] Cycloaddition of 2-Isocyanatomalonate Esters and Unsaturated Imines: Synthesis of Highly Substituted Chiral g-Lactams by Espinosa, Miguel et al.
 
Document downloaded from: 
 
This paper must be cited as:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The final publication is available at 
 
 
Copyright 
 
Additional Information 
 
http://hdl.handle.net/10251/153234
Espinosa, M.; Blay, G.; Cardona, L.; Muñoz Roca, MDC.; Pedro, JR. (2017). Catalytic
Asymmetric Formal [3+2] Cycloaddition of 2-Isocyanatomalonate Esters and Unsaturated
Imines: Synthesis of Highly Substituted Chiral g-Lactams. Chemistry - A European Journal.
23(59):14707-14711. https://doi.org/10.1002/chem.201702777
https://doi.org/10.1002/chem.201702777
John Wiley & Sons
 Communication 
 
 
 
 
 
& Asymmetric Catalysis 
 
Catalytic Asymmetric Formal [3+2] Cycloaddition of 
2-Isocyanatomalonate Esters and Unsaturated Imines : 
Synthesis of Highly Substituted Chiral g-Lactams 
 
Miguel Espinosa,[a] Gonzalo Blay,*[a]  Luz Cardona,[a]  M. Carmen MuÇoz,[b]  and Jos8 R. Pedro*[a] 
 
 
Abstract : Unlike their isocyano and isothiocyanato ana- 
logues, isocyanato esters remain almost unexplored as 
formal 1,3-dipoles in asymmetric catalytic reactions. The 
first asymmetric formal [3+2] cycloaddition involving iso- 
cyanato esters and electrophilic alkenes is reported. Diiso- 
propyl 2-isocyanatomalonate  reacts with a,b-unsaturated 
N-(o-anisidyl)  imines in the presence of a Mg(OTf)2–BOX 
complex to  give highly substituted chiral pyrrolidinones 
featuring a conjugate exocyclic double bond with excel- 
lent yields and enantiomeric excesses up to 99 %. Several 
transformations  of  the  resulting heterocycles, including 
the synthesis of a pyroglutamic acid derivative, have been 
carried out. 
 
 
 
 
Pyrrolidinones  (g-lactams) and, in particular,  2-alkoxycarbonyl- 
pyrrolidinones (pyroglutamic acid derivatives) have been ex- 
tensively used as building blocks in synthetic chemistry[1] and 
as chiral ligands in asymmetric catalysis.[2] They are also struc- 
tural units frequently encountered in  numerous biologically 
active natural products and pharmaceuticals  (Figure 1). Exam- 
ples include the marine metabolite (@)salinosporamide A, cur- 
rently tested as  an anticancer drug candidate,[3] the protea- 
some inhibitors antiprotealide and lactacystin,[4]  the antibiotic 
and antitumoral compound neooxazolmycin,  isolated form a 
strain of Streptomyces,[5]   the neuroexcitotoxic dysibetaine, iso- 
lated from the Micronesian sponge Dysidea herbacea,[6]  or the 
lipooligosaccharides found in the cell wall of different myco- 
bacteria.[7] 
Given the widespread chemical significance of these scaf- 
folds, the development of new efficient and atom-economic 
processes  for the construction of these heterocyclic systems, 
especially in an enantioselective manner, constitutes an impor- 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Examples of bioactive natural compounds incorporating a pyrroli- 
dinone unit. 
 
 
tant challenge in current organic synthesis. Besides procedures 
based on the  structural modification of  nitrogen-containing 
heterocycles,  such as pyrrolidinones, pyroglutamic acid, or suc- 
cinimides,[8]  cyclization procedures in which the pyrrolidinone 
heterocycle is formed from acyclic precursors result especially 
appealing. The Michael addition/lactamization reaction of 2- 
amino acids and unsaturated acid derivatives is one of the first 
used procedures for the synthesis of g-lactams.[9]   Recently, the 
double Michael addition of amide-tethered diacids with alky- 
nones[10] and the Conia–ene  reaction of alkynyl amidomalo- 
nates[11] have been used in the synthesis of pyroglutamic acid 
derivatives. However, most of the methods for the enantiose- 
lective synthesis of pyrrolidinones  are still based on chiral start- 
ing materials or stoichiometric reagents,[12]  and only few asym- 
metric catalytic procedures are available. Among them, enan- 
tioselective versions of the Michael addition/lactamization  reac- 
tion of 2-amino acids and unsaturated acid derivatives have 
been reported by several groups.[13]  Chiral g-lactams have been 
obtained with excellent enantioselectivities through N-hetero- 
cyclic carbene-catalyzed coupling of imines with unsaturated 
aldehydes.[14]   Finally,  the reaction between 2-aminomalonates 
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bases to give a-methylene-g-lactams with moderate enantiose- 
lectivity has been recently reported.[15] 
On the  other  hand, 2-isocyano[16] and 2-isothiocyanato[17] 
esters have been increasingly used as  formal 1,3-dipoles in 
asymmetric synthesis  over the last years. These compounds 
react with  different unsaturated groups to  give a variety of 
five-membered nitrogen-containing heterocycles. In particular, 
their participation in asymmetric catalytic formal [3+2]  cyclo- 
addition  reactions  with  conjugate carbonyl compounds  has 
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Table 1. Enantioselective [3+2]   cycloaddition  of   isocyanatomalonate 
esters with the unsaturated imine 4 a. Optimization of the reaction condi- 
[a] 
Entry  M L Solvent   R T [8C]   t [h]  Yield [%][b]   ee [%][c] 
1 La(OTf)3        pyBOX1 CH2Cl2     Et 25 3 81 3 
2 Ca(OTf)2       pyBOX1 CH2Cl2     Et 25 3.5 89 @67 
3 Mg(OTf)2  BOX1 CH2Cl2         Et 25 2 97 @67 
4 Mg(OTf)2  BOX2 CH2Cl2         Et 25 2.5 83 @5 
5 Mg(OTf)2  BOX3 CH2Cl2         Et 25 2.5 89 @5 
6 Mg(OTf)2  BOX4 CH2Cl2         Et 25 3 94 63 
7 Mg(OTf)2  BOX5 CH2Cl2         Et 25 3 97 29 
8 Mg(OTf)2  BOX6 CH2Cl2         Et 25 2.5 97 71 
9 Mg(OTf)2  BOX6 CH2Cl2         Et 0 3 96 80 
10 Mg(OTf)2  BOX6 CH2Cl2         Et   @20     45 68 43 
11 Mg(OTf)2  BOX6 CH2Cl2         Me 0 2 98 49 
12 Mg(OTf)2  BOX6 CH2Cl2         iPr 0 2 98 89 
13 Mg(OTf)2  BOX6 (ClCH2)2 iPr 0 2.5 98 76 
14 Mg(OTf)2  BOX6 CHCl3 iPr 0 2.5 89 91 
15 Mg(OTf)2  BOX6 Et2O iPr 0 2.5 96 91 
16 Mg(OTf)2  BOX7 Et2O iPr 0 1.5 97 97 
[a] Reaction conditions:  compounds 1–3  (0.19 mmol), compound  4a 
(0.125 mmol, C=N  geometry isomer mixture), L  (0.0125 mmol, M(OTf)2 
(0.0125 mmol), 4 a MS (110 mg), solvent (1.1 mL). [b] Yield of the isolated 
product. [c] Determined by HPLC with chiral stationary phases; opposite 
signs indicate opposite enantiomers. 
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Scheme 1. Formal [3+2] cycloadditions. 
 
 
provided a straightforward access to enantiomerically enriched 
pyrrolidines[18] or thiopyrrolidinones,[19] respectively (Scheme 1). 
Following  these antecedents,  we  envisaged that  a  formal 
[3+2]   cycloaddition  between  a  2-isocyanato esters and  a 
proper Michael acceptor may be used for the efficient and 
atom-economic  enantioselective synthesis of 2-alkoxycarbonyl- 
pyrrolidinones (Scheme 1). However,  the use of 2-isocyanato 
esters in reactions that combine both nucleophilic and electro- 
philic behavior (1,3-dipole-like behavior) is challenging due to 
the higher reactivity of the isocyanate group compared to the 
isocyano and isothiocyanate groups.  In fact, 2-isocyanato 
esters have been mainly used as electrophiles  for the prepara- 
tion of ureas and carbamates,[20]  whereas reactions making use 
of their 1,3-dipole-like character are almost unknown. To the 
best of our knowledge, the organocatalytic reaction of 2-iso- 
cyanatomalonate  esters and aldehydes to give oxazolidinones 
developed by Takemoto et al. ,[21]  is the only example reported 
in the literature so far.[22]  Following our research on the use of 
1-aza-butadienes as electrophiles,[23]   we report here the first ex- 
ample of enantioselective formal [3+2] cycloaddition reactions 
of 2-isocyanato  esters with alkenes to give highly substituted 
a,b-unsaturated g-lactams. The reaction is carried out by using 
unsaturated imines, 2-isocyanatomalonate  esters, and a Mg- 
BOX complex as catalyst (Scheme 2). 
We initially investigated the activity of the LaIII–pyBOX1, CaII– 
pyBOX1, and MgII–BOX1 complexes in the reaction between di- 
ethyl 2-isocyanatomalonate (1) and the imine 4a derived from 
o-anisidine (Table 1, entries 1–3).[24] In all cases,  the  reaction 
proceeded smoothly to give the pyrrolidinone 5 a, which fea- 
tures a conjugated exocyclic double bond, a structural moiety 
that is present in a large number of antitumor compounds. 
Compound 5a was obtained as a single geometric isomer 
having the Z configuration at the double bond. Regarding the 
enantioselectivity,  the LaIII–pyBOX1  complex gave compound 
5a in almost racemic form, whereas the CaII–pyBOX1 and MgII– 
BOX1 complexes  showed similar enantioselectivities (ee = 67 %, 
ee = enantiomeric excess),  although the magnesium complex 
seemed slightly  more active. Further research was continued 
by testing several Mg–BOX complexes. The best result was ob- 
tained with BOX6 that provided compound 5a in 97 % yield 
with 71 % ee (Table 1, entry 8). A decrease of the temperature 
 
 
 
 
Scheme 2. Formal [3+2] cycloaddition between 2-isocyanatomalonates and 
unsaturated imines, and ligands used in this study. 
 
 
 
 
tions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
to 0 8C  increased  the ee  up to 80 %, however,   a further de- 
crease of the temperature to @20 8C produced a dramatic drop 
of the enantioselectivity (Table 1, entries 9 and 10). With the 
optimal temperature (0 8C),  the effect of the alkoxy group in 
the 2-isocyanatomalonate ester was tested (Table 1, entries 9, 
11, and 12). 
It was found that the diisopropyl ester 3 underwent a more 
enantioselective reaction than diethyl or dimethyl 2-isocyana- 
tomalonates, giving lactam 7a in 98 % yield with 89 % ee. Next, 
the effect of the solvent was checked. The use of diethyl ether 
as the solvent in the addition of compound 3 to compound 
4a allowed increasing the ee  of compound 7a up to  91 % 
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(Table 1, entry 15). Finally,  in view of the important effect of 
the substitution at the central carbon atom of the BOX ligand 
on the enantioselectivity of the reaction (Table 1, entry 7 vs. 
entry 8), the  cyclopropylic BOX7 ligand  was prepared and 
tested providing compound 7a in excellent 97 % yield and 
97 % ee (Table 1, entry 16). 
With the best conditions available the scope of the reaction 
of diisopropyl 2-isocyanatomalonate (3) and the a,b-unsaturat- 
ed N-(o-methoxyphenyl)imines 4[25] by using the Mg(OTf)2– 
BOX7 (Tf = triflate) complex as catalyst  was studied. The results 
are gathered in Table 2. The reaction can be carried out with 
 
 
Table 2. Enantioselective  [3+2]  cycloaddition of  2-isocyanatomalonate 
esters with the unsaturated imines 4. Scope of the reaction.[a] 
 
Entry   R R1 R2 t [h]   5–7   Yield [%][b]     ee [%][c] 
1 iPr   Ph Ph 1.5   7a 97 97 
2 iPr   p-ClC6H4 Ph 1.5   7b 93 96 
3 iPr   p-NO2C6H4 Ph 1.5   7c 98 98 
4 iPr   p-MeOC6H4       Ph 1.5   7d 98 96 
5 iPr   2-furanyl Ph 1 7e 98 88 
6 iPr   tBu Ph 20 7 f 26 23 
7 iPr   Ph p-ClC6H4 1.5   7g 94 99 
8 iPr   Ph p-NO2C6H4 1 7h 98 95 
9 iPr   Ph p-MeOC6H4 1 7 i 97 98 
10 iPr   Ph m-NO2C6H4 3 7 j 87 97 
11 iPr   Ph o-ClC6H4 1.5   7k 98
[d] 98[e] 
12 iPr   Ph o-NO2C6H4 27 7 l 98
[d] 99 
13 iPr   Ph 2-furanyl 1 7m   98 83 
14 iPr   Ph 2-naphthyl 1 7n 98 98 
15 Et Ph Ph 1 5a 96 77 
16 Me   Ph Ph 1 6a 97 76 
17[f] iPr   Ph Ph 1.5   7a 96 94 
[a] Reaction   conditions:   compounds   1–3  (0.19 mmol),   compound  4 
(0.125 mmol),  BOX7 (0.0125 mmol,  Mg(OTf)2  (0.0125 mmol),   4 a   MS 
(110 mg), Et2O (1.1 mL), 0 8C.  [b] Yield of the isolated product. [c] Deter- 
mined by HPLC with chiral stationary phases. [d] Obtained as an about 
1:1 mixture of  Z/E  isomers.  [e] Determined after enamine hydrolysis. 
[f] Reaction carried out with 1.6 mmol of compound 4 a. 
 
 
imines bearing at the b-carbon atom an aromatic ring substi- 
tuted with either electron-withdrawing (Table 2, entries 2 and 
3) or electron-donating groups (Table 2, entry 4), to give the 
expected products 7 b–7d with excellent yields and enantiose- 
lectivities.  The residue R1 can also be a heterocyclic furanyl ring 
(Table 2, entry 5). In this case, compound 7e was obtained in 
almost quantitative yield and slightly lower ee (88 %). The in- 
troduction of a bulky tert-butyl group at the b-carbon atom 
brought about a decrease of the reaction rate and the expect- 
ed lactam 7 f was obtained with low yield and enantioselectivi- 
ty (Table 2, entry 6). 
The R2  group attached to the azomethinic carbon atom was 
also amenable to  variation (Table 2, entries 7–14). Aromatic 
rings bearing either electron-withdrawing or electron-donating 
groups were permitted without  showing much influence on 
the enantioselectivity of the reaction. Again, when R2  was a 2- 
furanyl group, compound 7m was obtained with lower ee, al- 
though with high yield (Table 2, entry 13). A naphthyl group at- 
tached to the imine was also tolerated, compound 7n being 
obtained in 98 % yield and 98 % ee (Table 2, entry 14). As antici- 
pated, diethyl  and  dimethyl  2-isocyanatomalonates  reacted 
with compound 4a to give the expected lactams with lower 
enantioselectivity than  diisopropyl  2-isocyanatomalonate 
(Table 2, entries 15 and 16). To further demonstrate the practi- 
cality of this newly developed procedure, the reaction of com- 
pounds  3  and  4a  was carried out  on  a  1.6 mmol  scale 
(500 mg). Product 7a was obtained in 96% yield with minimal 
erosion in the enantioselectivity (94 % ee, Table 2, entry 17). 
In all the examples studied except with the imines 4k and 
4 l,  which have an o-substituted phenyl ring attached to the 
azomethinic carbon atom, compounds 5–7 were obtained as a 
single diastereomer. Compound 7b (Table 2, entry 2) could be 
crystallized and subjected to X-ray analysis,[26]  what allowed to 
establish the geometry of the enamine double bond as Z and 
the configuration of the stereogenic center as R (Figure  2). The 
absolute stereochemistry of all compounds 5–7 was assigned 
by analogy upon the assumption of a uniform stereochemical 
pathway. 
 
 
 
 
Figure 2. ORTEP plot for the X-ray structure of compound 7b. The thermal 
ellipsoids are drawn at the 50 % probability level. Flack parame- 
ter = @0.16(8). 
 
 
Some transformations  were carried out  on compound 7a 
(Scheme 3). Thus, aqueous hydrolysis of the enamine with con- 
centrated HCl in THF gave ketone 8a in 90 % yield. On the 
other hand, treatment of compound 3a with NaBH3CN–AcOH 
(Ac = acyl) in EtOH  provided the major amine 9 a[26]  in 75 % 
yield, together  with  an isomeric amine 9 a’’,  whose stereo- 
chemistry could not be assigned, in 11 % yield. Also, the che- 
moselective transesterification  of the diisopropyl ester 7a to 
give the mixed diester 10 a was efficiently achieved in 89 % 
yield by treatment with NaOMe/MeOH. Finally,  the pyrogluta- 
mic acid derivative 11 a was obtained in 87 % yield after hy- 
drolysis/decarboxylation   upon   treatment   of   compound   7 a  
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Scheme 3. Ar = o-MeOC6H4. i) HCl, THF, RT, yielding product 8a in 90 %. ii) 
NaBH3CN, AcOH, EtOH, 0 8C, yielding product 9a in 75 and product 9a’’ (i.e. , 
a diastereomer of compound 9a) in 11%. iii) NaOMe/MeOH, 65 8C yielding 
compound 10 a in 89 %. iv) Et4NOH, DMSO, 80 8C, yielding compound 11 a in 
87 %. 
 
 
with an excess of tetraethylammonium hydroxide in DMSO at 
80 8C. All these reactions took place without  a noticeable loss 
of enantiomeric excess with respect to the starting compound 
7 a. 
A simplified  mechanistic proposal for the [3+2]  cycloaddi- 
tion is outlined in Scheme 4. Thus, initial coordination of both 
reaction partners to the MgII–BOX complex would bring about 
a nucleophilic activation of the malonate ester through enoli- 
zation together with electrophilic activation of the imine (inter- 
mediate I). Conjugate addition would lead to the enamine in- 
termediate II,  which would undergo nucleophilic addition to 
the isocyanate group giving the lactam III. Finally, imine/enam- 
ine tautomerization and decoordination would give the final 
products and release the catalyst. 
 
 
 
 
Scheme 4. Simplified mechanistic proposal for the [3+2] cycloaddition. 
Mg* = Mg-BOX. 
 
 
In summary, we have reported the first enantioselective 
formal  [3+2]   cycloaddition  of  2-isocyanatomalonate esters 
with electrophilic alkenes. By using a Mg(OTf)2–BOX complex 
as  catalyst,  diisopropyl isocyanatomalonate reacted with a,b- 
unsaturated N-(o-anisidyl)  imines to give highly substituted 
chiral pyrrolidinones  featuring a conjugate exocyclic double 
bond. The reaction products, which are derivatives of pyroglu- 
tamic acid, were obtained with excellent yields and high to ex- 
cellent enantioselectivities for a significant number of unsatu- 
rated imines. The use of the N-(o-anisidyl) group was essential 
for the success of the reaction as neither the unsaturated 
ketone nor the unsaturated N-tosyl imine were reactive with 
this catalyst. Furthermore, the reaction does not require the 
use of diastereomerically pure imines, instead mixtures of C=N 
geometric isomers can be used. The application of non-expen- 
sive and non-toxic MgII salts as Lewis  acids is another advant- 
age of this procedure. We believe that this reaction will open 
new possibilities for  the  potential  application of  isocyanato 
esters as  formal 1,3-dipoles in asymmetric catalytic reactions. 
Research toward this  goal is currently under progress in our 
laboratory 
 
 
Experimental Section 
 
General  procedure  for  the  formal  [3+2]  reaction :   Mg(OTf)2 
(4.0 mg, 0.0125 mmol) was dried in a Schlenk tube under vacuum. 
BOX7 (6.1 mg, 0.0125 mmol) was introduced and the Schlenk tube 
was filled with nitrogen. Et2O (0.55 mL) was added through a sy- 
ringe and the mixture was stirred for 30 min. The tube was intro- 
duced in a bath at 0 8C, 4 a MS (110 mg) was then added followed 
by the corresponding imine (0.125 mmol) dissolved in dry Et2O 
(0.5 mL)   and   by    diisopropyl   2-isocyanatomalonate  (37 mL, 
0.19 mmol). The mixture was stirred at 0 8C for the indicated time 
and purified by column chromatography on silica gel eluting with 
hexane/EtOAc mixtures to give compounds 7. Compounds  5 and 6 
were prepared following the same procedure by using diethyl or 
dimethyl 2-isocyanatomalonate, respectively. 
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